Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 7, Issue 7, Pages 692-696Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.6b00120
Keywords
Dihydrofolate reductase; antifolate; MRSA; Staphylococcus aureus; Escherichia coli; trimethoprim; methotrexate
Categories
Funding
- NIH [AI104841, AI111957]
Ask authors/readers for more resources
Although classical, negatively charged antifolates such as methotrexate possess high affinity for the dihydrofolate reductase (DHFR) enzyme, they are unable to penetrate the bacterial cell wall, rendering them poor antibacterial agents. Herein, we report a new class of charged propargyl-linked antifolates that capture some of the key contacts common to the classical antifolates while maintaining the ability to passively diffuse across the bacterial cell wall. Eight synthesized compounds exhibit extraordinary potency against Gram-positive S. aureus with limited toxicity against mammalian cells and good metabolic profile. High resolution crystal structures of two of the compounds reveal extensive interactions between the carboxylate and active site residues through a highly organized water network.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available